Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL

Peripheral T-cell lymphomas (PTCLs) have marked biologic and clinical heterogeneity, which confounds treatment decisions. Advances in circulating tumor DNA (ctDNA) assays using next-generation sequencing (NGS) have improved the detection of molecular relapse and driver mutations in diffuse large B-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Miljkovic, Milos D., Melani, Christopher, Pittaluga, Stefania, Lakhotia, Rahul, Lucas, Nicole, Jacob, Allison, Yusko, Erik, Jaffe, Elaine S., Wilson, Wyndham H., Roschewski, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945631/
https://www.ncbi.nlm.nih.gov/pubmed/34432874
http://dx.doi.org/10.1182/bloodadvances.2020003679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945631/
https://www.ncbi.nlm.nih.gov/pubmed/34432874
http://dx.doi.org/10.1182/bloodadvances.2020003679

Ejemplares similares